Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-small Cell Lung Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT05566223
What this trial is testing

CISH Inactivated TILs in the Treatment of NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell LungMetastatic Non Small Cell Lung CancerStage IV Non-small Cell Lung Cancer+3 more
Intima Bioscience, Inc.
Large-scale testing (Phase 3)Study completedNCT00002550
What this trial is testing

Chemotherapy Plus Radiation Therapy With or Without Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 429
Early research (Phase 1)Study completedNCT00890747
What this trial is testing

Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAcute Undifferentiated Leukemia+82 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Looking for participantsNCT07145255
What this trial is testing

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

Who this might be right for
Prostate Cancer Castration-resistant Prostate CancerBreast CancerColo-rectal Cancer+2 more
MBrace Therapeutics 150
Large-scale testing (Phase 3)Ended earlyNCT00673049
What this trial is testing

Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer

Who this might be right for
Carcinoma, Large CellCarcinoma, Non-Small-Cell LungCarcinoma, Squamous Cell+1 more
Pfizer 583
Testing effectiveness (Phase 2)Study completedNCT00043368
What this trial is testing

PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909)

Who this might be right for
MelanomaBreast NeoplasmsCarcinoma, Renal Cell+2 more
Pfizer 31
Early research (Phase 1)Study completedNCT00655655
What this trial is testing

Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors

Who this might be right for
GastrinomaGlucagonomaInsulinoma+17 more
Mayo Clinic 96
Large-scale testing (Phase 3)Active Not RecruitingNCT03815643
What this trial is testing

Avelumab Program Rollover Study

Who this might be right for
Solid Tumors
EMD Serono Research & Development Institute, Inc. 205
Post-approval studies (Phase 4)Not Yet RecruitingNCT06785584
What this trial is testing

Efficacy and Safety of Ensartinib in Neoadjuvant Therapy for Stage IIA - IIIB (Operable or Potentially Operable) ALK-Positive Lung Adenocarcinoma ：A Multicenter, Real-World Clinical Study

Who this might be right for
ALK-positive Advanced NSCLCALK-positive Non-small Cell Lung Cancer (NSCLC)MPR+1 more
Fujian Medical University Union Hospital 30
Early research (Phase 1)Looking for participantsNCT06270706
What this trial is testing

PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumor
Pliant Therapeutics, Inc. 124
Not applicableStudy completedNCT00428220
What this trial is testing

A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.

Who this might be right for
Metastatic Breast CancerAdvanced Breast CancerMetastatic Castration Resistant Prostate Cancer+9 more
Pfizer 223
Early research (Phase 1)Study completedNCT04440943
What this trial is testing

The PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies

Who this might be right for
Non-small Cell Lung CancerBreast CancerGastric Cancer+11 more
Celldex Therapeutics 27
Early research (Phase 1)Study completedNCT06894771
What this trial is testing

MK-4700 Alone or With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors (MK-4700-001)

Who this might be right for
Malignant Neoplasm
Merck Sharp & Dohme LLC 5
Early research (Phase 1)Study completedNCT03415126
What this trial is testing

ASN007 in Patients With Advanced Solid Tumors

Who this might be right for
CancerMalignancyNeoplasia+16 more
Asana BioSciences 49
Early research (Phase 1)Ended earlyNCT01115803
What this trial is testing

LY2584702 With Erlotinib or Everolimus in Participants With Solid Tumors

Who this might be right for
Metastases, NeoplasmCarcinoma, Non-small Cell LungRenal Cell Carcinoma+1 more
Eli Lilly and Company 29
Early research (Phase 1)Ended earlyNCT05462873
What this trial is testing

Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungCarcinoma, Renal CellEsophageal Squamous Cell Carcinoma+1 more
Novartis Pharmaceuticals 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05651022
What this trial is testing

Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultHCC - Hepatocellular CarcinomaCRC (Colorectal Cancer)+5 more
Indaptus Therapeutics, Inc 120
Testing effectiveness (Phase 2)Looking for participantsNCT05363280
What this trial is testing

Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment

Who this might be right for
Small Cell Lung CancerRenal Cell Carcinoma (RCC)Non-Small Cell Lung
Advenchen Pharmaceuticals, LLC. 80
Testing effectiveness (Phase 2)Study completedNCT01156545
What this trial is testing

BIBW 2992 Plus Simvastatin vs. BIBW 2992 in Previously Treated Patients With Advanced Non-adenocarcinomatous NSCLC

Who this might be right for
Non-small Cell Lung Cancer
National Cancer Center, Korea 68
Testing effectiveness (Phase 2)Study completedNCT00042679
What this trial is testing

Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.

Who this might be right for
Carcinoma, Non-Small-Cell LungPulmonary NeoplasmsNeoplasms, Lung
Eli Lilly and Company
Next Page